Dr. Hackam is a scientist at the Robarts Research Institute, Stroke Prevention and Atherosclerosis Research Centre. His research is diverse and focuses on the pharmacoepidemiology of atherosclerosis, risk factor assessment, and translation of novel findings from basic science to clinical trials. His background includes training in biology, medicine, internal medicine, clinical pharmacology, cardiac rehabilitation, clinical epidemiology, and health services research. Dr. Hackam's publications have appeared in The Lancet, JAMA, Circulation, Stroke, American Journal of Medicine, CMAJ, BMJ, and in numerous research forums and symposia.